Ovarian Seromucinous Tumor

specific

A benign, borderline, or malignant mixed epithelial tumor of the ovary. It is characterized by the presence of more than one epithelial cell type, most often serous and endocervical-type mucinous.

Centers

Active Trials

—

Cancer Funding

Top Centers for Ovarian Seromucinous Tumor(13)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Active Trials	Cancer Funding	Score
1	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive	—	—	53.8
2	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins UniversityBaltimore, MD NCI Comprehensive	—	—	53.8
3	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive	—	—	53.8
4	University of Colorado Cancer CenterAurora, CO NCI Comprehensive	—	—	53.8
5	Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive	—	—	53.8
6	Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive	—	—	53.8
7	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive	—	—	53.8
8	Cleveland Clinic Cancer CenterCleveland, OH	—	—	53.8
9	Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive	—	—	53.8
10	University of Illinois Cancer CenterChicago, IL	—	—	53.8
11	Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive	—	—	53.8
12	Cancer Center at IllinoisUrbana, IL	—	—	53.8
13	Georgia Cancer Center, Augusta UniversityAugusta, GA	—	—	53.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →